"Clinical Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
Descriptor ID |
D002986
|
MeSH Number(s) |
E05.318.760.250.500 N05.715.360.775.088.500 N06.850.520.450.250.250
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Clinical Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Clinical Trials as Topic".
This graph shows the total number of publications written about "Clinical Trials as Topic" by people in this website by year, and whether "Clinical Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 4 | 5 |
1996 | 2 | 5 | 7 |
1997 | 3 | 5 | 8 |
1998 | 1 | 5 | 6 |
1999 | 1 | 9 | 10 |
2000 | 2 | 9 | 11 |
2001 | 1 | 3 | 4 |
2002 | 1 | 9 | 10 |
2003 | 5 | 23 | 28 |
2004 | 5 | 19 | 24 |
2005 | 8 | 27 | 35 |
2006 | 2 | 20 | 22 |
2007 | 2 | 20 | 22 |
2008 | 7 | 20 | 27 |
2009 | 10 | 17 | 27 |
2010 | 3 | 18 | 21 |
2011 | 7 | 9 | 16 |
2012 | 9 | 15 | 24 |
2013 | 11 | 14 | 25 |
2014 | 12 | 20 | 32 |
2015 | 6 | 13 | 19 |
2016 | 10 | 8 | 18 |
2017 | 4 | 11 | 15 |
2018 | 8 | 10 | 18 |
2019 | 6 | 12 | 18 |
2020 | 8 | 13 | 21 |
2021 | 2 | 7 | 9 |
2022 | 1 | 10 | 11 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Clinical Trials as Topic" by people in Profiles.
-
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review. JAMA Psychiatry. 2023 01 01; 80(1):84-92.
-
When perfection is the enemy of good: EBM lessons from the HIP trial. J Perinatol. 2023 02; 43(2):253-256.
-
Interpretable machine learning predicts cardiac resynchronization therapy responses from personalized biochemical and biomechanical features. BMC Med Inform Decis Mak. 2022 10 31; 22(1):282.
-
Patient-reported outcomes following cemented versus cementless primary total knee arthroplasty: a comparative analysis based on propensity score matching. BMC Musculoskelet Disord. 2022 Oct 27; 23(1):934.
-
Dementia with Lewy bodies: Impact of co-pathologies and implications for clinical trial design. Alzheimers Dement. 2023 01; 19(1):318-332.
-
Hemorrhagic Stroke in Children and Adults With Sickle Cell Anemia: The Post-STOP Cohort. Stroke. 2022 11; 53(11):e463-e466.
-
An adaptive clinical trial design to identify the target dose of tenecteplase for treatment of acute pulmonary embolism. Clin Trials. 2022 Dec; 19(6):636-646.
-
Effects of Buprenorphine Dose and Therapeutic Engagement on Illicit Opiate Use in Opioid Use Disorder Treatment Trials. Int J Environ Res Public Health. 2022 03 30; 19(7).
-
Early Trajectory of Estimated Glomerular Filtration Rate and Long-term Advanced Kidney and Cardiovascular Complications in Type 1 Diabetes. Diabetes Care. 2022 03 01; 45(3):585-593.
-
Single-arm clinical trials that supported FDA accelerated approvals have modest effect sizes and were at high risk of bias. J Clin Epidemiol. 2022 08; 148:193-195.